Key Facts Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline Programs featured: selective p300 and PRMT5 degraders p300 degrader data demonstrate: Deep anti-tumor activity in CBP mutant cancers (synthetic lethality) Broad efficacy...
Hence then, the article about sk life science labs to present new preclinical data on targeted protein degradation at aacr annual meeting 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( SK Life Science Labs to Present New Preclinical Data on Targeted Protein Degradation at AACR Annual Meeting 2026 )
Also on site :
- 57-year-old woman killed in Lake Geneva boat accident on as busy boating season begins
- Telegraph’s new German owner imposes pro-Israel bias – journalist
- Istanbul Film Festival’s Meetings on the Bridge Co-Production Platform Wraps With Prizes for Standout Turkish Projects